For years, Oregon has been building a world-class biotech sector to rival research hubs like Boston and San Diego. But some in the industry say it could develop more breakthroughs and treatments with a state assist. In this week's PBJ cover story, reporter Elizabeth Hayes explores what an R&D tax credit would mean for Oregon's biotech firms — and to the state's budget. Read Story.
No comments:
Post a Comment